Mixed cerebrovascular disease and the future of stroke prevention

Insights

Stroke prevention needs to address mixed cerebrovascular disease, encompassing both ischemic and hemorrhagic conditions. This unified approach aids risk stratification and identifies therapies like PDE inhibitors for comprehensive stroke care.

Area of Science:

  • Neurology
  • Cerebrovascular Disease Research
  • Pharmacology

Background:

  • Current stroke prevention strategies often focus narrowly on either ischemic or hemorrhagic stroke.
  • This singular focus is insufficient due to the common co-occurrence of both ischemic and hemorrhagic conditions in patients.
  • This co-occurrence, termed mixed cerebrovascular disease, necessitates a more integrated approach to prevention and treatment.

Purpose of the Study:

  • To introduce and advocate for the concept of "mixed cerebrovascular disease" as a unifying framework for stroke prevention.
  • To highlight the clinical and subclinical syndromes encompassed by mixed cerebrovascular disease.
  • To explore potential therapeutic strategies, such as phosphodiesterase (PDE) inhibitors, for managing this complex condition.

Main Methods:

  • Review and synthesis of existing literature on ischemic and hemorrhagic stroke.
  • Identification of clinical and subclinical syndromes associated with mixed cerebrovascular disease.
  • Exploration of animal models for understanding hemorrhagic cerebrovascular disease mechanisms.
  • Evaluation of therapeutic agents, specifically PDE inhibitors, for their dual-action potential.

Main Results:

  • Mixed cerebrovascular disease includes conditions like ischemic stroke, subclinical infarcts, leukoaraiosis, intracerebral hemorrhage, and cerebral microbleeds.
  • Recognizing mixed cerebrovascular disease can improve risk stratification for hemorrhagic complications from antiplatelet and anticoagulant therapies.
  • Animal models of cerebral amyloid angiopathy and hypertension provide insights into hemorrhagic stroke mechanisms.
  • Phosphodiesterase (PDE) inhibitors show promise due to their ability to target both platelets and the vessel wall.

Conclusions:

  • A "mixed cerebrovascular disease" framework offers a more comprehensive approach to stroke prevention than focusing on single stroke types.
  • This framework aids in assessing risks associated with antithrombotic therapies.
  • Targeting mechanisms underlying mixed cerebrovascular disease, potentially with agents like PDE inhibitors, is crucial for effective stroke prevention.

Related Concept Videos

Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Regulation of Stroke Volume01:27

Regulation of Stroke Volume

The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...